Gero Competitors and Similar CompaniesClear all
Gero's competitors and similar companies include Taiwan Liposome and Sanofi Genzyme.
 Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. |  Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | |
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 1981 |
Type | Type Private | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more |
Employees | Employees 105 | Employees 1652% decrease | Employees 9,9041% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) €10.4b (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Taiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View company